Results 101 to 110 of about 52,201 (157)

Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.

JAMA Intern Med
Rossouw JE, Aragaki AK, Manson JE, Szmuilowicz ED, Harrington LB, Johnson KC, Allison M, Haring B, Saquib N, Shadyab AH, Rexrode KM, Liu L, Mouton CP, LaCroix AZ.   +13 more
europepmc   +1 more source

Sleeping Through Menopause: study protocol of a randomized controlled trial of menopausal hormone therapy and online guided cognitive behavioural and circadian therapy for insomnia in perimenopausal women suffering from insomnia

van Baarzel F, Broekman BF, van Dijken DK, MenoPause Consortium, van Someren EJ, Koning AC.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Menopausal Hormone Therapy

Journal of Obstetrics and Gynaecology Canada, 2005
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Bhagu R, Bhavnani, Ronald C, Strickler
openaire   +3 more sources

Menopausal hormone therapy and menopausal symptoms

Fertility and Sterility, 2014
A majority of women will experience bothersome symptoms related to declining and/or fluctuating levels of estrogen during their menopausal transition. Vasomotor symptoms, vaginal dryness, poor sleep, and depressed mood have all been found to worsen during the menopausal transition.
Zain A, Al-Safi, Nanette, Santoro
openaire   +2 more sources

Bleeding with menopausal hormone therapy

Best Practice & Research Clinical Obstetrics & Gynaecology, 2009
Hormone therapy is highly effective for the treatment of menopausal vasomotor symptoms and vaginal dryness, but commonly leads to unscheduled vaginal bleeding and spotting. This frequently leads to invasive investigations to exclude underlying malignancy and is also very unpopular amongst users.
Martha, Hickey, Sweta, Agarwal
openaire   +2 more sources

Update on menopausal hormone therapy

Current Opinion in Endocrinology, Diabetes & Obesity, 2015
Menopause management has undergone an eventful journey over the past decade; some dogmas got refuted, some new hypotheses took life, and the review is timely and relevant to the practice of clinical medicine in 2015.The field stepped out of an era of absolutes into times of patient centeredness and an individualized perspective.The onus now is to ...
Tugba Altun, Ensari, Lubna, Pal
openaire   +2 more sources

Hormone Therapy in Menopause

2020
As longevity expands, women are spending a third of their existence in menopause and beyond. The vast majority suffer from symptoms that negatively impact their quality of life. Systemic vasomotor symptoms (VMS) are the classic cluster affecting 80% of peri- and post-menopausal women.
openaire   +2 more sources

Menopause and Hormone Replacement Therapy

Clinics in Geriatric Medicine, 1993
The beneficial impact of hormone replacement therapy on postmenopausal women is substantial. The size of the positive impact has probably been underestimated owing to compliance issues. Patients and physicians need to learn about the important contribution to preventive health care that occurs with estrogen.
openaire   +2 more sources

Hormone Therapy: Menopausal Hormone Therapy.

FP essentials, 2023
The marked decrease in estrogen levels in menopausal women can cause bothersome symptoms that affect daily life. More than 75% of women experience menopausal symptoms, which can include vaginal dryness, itching, discharge, dyspareunia, mood changes, hot flushes, and night sweats.
openaire   +1 more source